On June 1, the medical website, fengfeng, moved into the circulation of medicine. However, traditional drug companies will fight back! In addition, its pharmaceutical unit has been identified by the pharmaceutical department.
▍ guangdong food drug administration along abundant medical attendance
On May 31, the guangdong food and drug administration issued a notice on the drug GSP deadline (no. 73 in 2017).
In the follow-up examination of guangdong food and drug administration, 14 drug companies were ordered to complete the correction within one month after they did not comply with GSP regulations. The 14 companies, including the "shunfeng pharmaceutical supply chain co., LTD.", which has just received a third party logistics qualification for pharmaceutical products.
The announcement showed that on April 26, 2017, a follow-up examination by the ministry of food and drug administration found that the company's drug quality management system had a general defect (03402). The so-called 03402 defect code, the "invalid file is present at work".
▍ just got qualification, problems were found
According to the public information, the registered capital of shunfeng pharmaceutical supply chain co., LTD. Is 50 million yuan, which was founded on July 29, 2015. Its business scope includes third-party drugs modern logistics business (entrusted drug production enterprise storage distribution drugs, drugs with the exception of special control), in February 2017 to get the medicine third-party logistics.
It's not big. However, medicine circulation enterprises always face the most tightly "four" regulation, superb fly, rule-breaking nuanced zhen bian, and enveloped the tense atmosphere above industry, this will let just enter this circle motion, feeling to the deep.
Break into the medical circle of the company, the rapid layout. Currently in nanjing, Beijing, heilongjiang, chengdu and guangdong, the planned distribution will cover more than half of China. In less than two years, the drug circulation industry has been around for a long time: be careful, it's coming.
▍ traditional medicine group of joint responses
According to people familiar with the matter, however, relative to other provinces, the current progress in central province motion is not very smooth, vehicle personnel are not on the scale, time is not short, not open markets. The blue on the basis of analysis, parker motion is powerful, there is also a big push into medical determination of third-party logistics, but if the local has a powerful regional leader, form a powerful network, such as motion'm afraid I can not break through.
Third party logistics, the biggest in the industry, are not the only ones. In fact, the opposite is true.
Guangdong, according to list released on 16 medicine qualification of the third party logistics companies, 14 are traditional medicine, China resources, state-controlled, batch of medicine, kyushu tong, etc. The same is true of the national situation at the end of 2015. Medical logistics, too, are firmly in the hands of existing drug giants.
The "outsiders", such as shunfeng and yutong, were in high fashion, and the drugs were ready to fight back.
According to the blue parker, working on some third-party medical logistics enterprises across the province cold chain alliance, once formed, will have a certain threshold of competition, and billing way also is no longer the traditional "point", but according to the pieces, weight, and by volume, according to the distance, such as integrated billing way, because of the long has more advantage of the customer resources, service fee is lower than motion.
It's coming, but it doesn't have to be. |